JD III - Trulieve Cannabis Chief Sec

All Insiders USA . 
Stock . Trulieve Cannabis Corp . Stakeholders . Insider . JD III
TCNNF Stock  USD 5.99  0.13  2.12%   

Insider

JD III is Chief Sec of Trulieve Cannabis Corp
Age 54
Phone850 480 7955
Webhttps://www.trulieve.com

Trulieve Cannabis Management Efficiency

The company has return on total asset (ROA) of 0.0479 % which means that it generated a profit of $0.0479 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1421) %, meaning that it generated substantial loss on money invested by shareholders. Trulieve Cannabis' management efficiency ratios could be used to measure how well Trulieve Cannabis manages its routine affairs as well as how well it operates its assets and liabilities.
Trulieve Cannabis Corp has accumulated 469.38 M in total debt with debt to equity ratio (D/E) of 0.47, which is about average as compared to similar companies. Trulieve Cannabis Corp has a current ratio of 3.21, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Trulieve Cannabis until it has trouble settling it off, either with new capital or with free cash flow. So, Trulieve Cannabis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Trulieve Cannabis Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Trulieve to invest in growth at high rates of return. When we think about Trulieve Cannabis' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Anne MoonTempest Therapeutics
N/A
MD MBARezolute
N/A
Michael PitznerMolecular Partners AG
N/A
, MBAMolecular Partners AG
51
Joseph HazeltonDyadic International
48
Petpiboon PrasitTempest Therapeutics
N/A
Dominic CundariDiaMedica Therapeutics
73
Daniel RyweckSilo Pharma
59
Alexander ZurcherMolecular Partners AG
49
Justin TrojanowskiTempest Therapeutics
36
Edward CalamaiDiaMedica Therapeutics
N/A
Antony CPAForte Biosciences
57
LLM JDRezolute
63
Dr DubenskyTempest Therapeutics
66
Steven RuhlForte Biosciences
67
Brian MDRezolute
49
RAC SakaiTempest Therapeutics
N/A
Patrick AmstutzMolecular Partners AG
49
Thomas SchwerzmannMolecular Partners AG
N/A
Christopher RoenfeldtForte Biosciences
N/A
Seth LewisMolecular Partners AG
N/A
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida. TRULIEVE CANNABIS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 8000 people. Trulieve Cannabis Corp [TCNNF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Return On Equity-0.14
Return On Asset0.0479

Trulieve Cannabis Corp Leadership Team

Elected by the shareholders, the Trulieve Cannabis' board of directors comprises two types of representatives: Trulieve Cannabis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Trulieve. The board's role is to monitor Trulieve Cannabis' management team and ensure that shareholders' interests are well served. Trulieve Cannabis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Trulieve Cannabis' outside directors are responsible for providing unbiased perspectives on the board's policies.
Kimberly Rivers, Chairman Founder
Rebecca Young, VP Officer
Alex CPA, Chief Officer
Robert Kremer, Exec Communications
JD III, Chief Sec
Jason Pernell, Chief Officer
Victoria Walker, Director Relations
Nilyum Jhala, Chief Officer
Christine Hersey, Director Relations
Steven White, President

Trulieve Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Trulieve Cannabis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.14
Return On Asset0.0479
Profit Margin(0.19) %
Operating Margin0.14 %
Current Valuation2.48 B
Shares Outstanding159.64 M
Shares Owned By Insiders8.76 %
Shares Owned By Institutions12.51 %
Price To Earning23.96 X
Price To Book0.83 X

Currently Active Assets on Macroaxis

RSIRush Street Interactive
OKTAOkta Inc
BACBank of America
SSentinelOne
WDWalker Dunlop

Other Information on Investing in Trulieve OTC Stock

Trulieve Cannabis financial ratios help investors to determine whether Trulieve OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Trulieve with respect to the benefits of owning Trulieve Cannabis security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY